Catasys — Investor Presentation (March 2015)
21 slides from Catasys's investor presentation, Mar 10, 2015
Slide 1: The Health Plan Solution to the High Cost of Substance Abuse
The Health Plan Solution to the High Cost of Substance Abuse WINTER 2015 OTCQB: CATS
Slide 2: Forward-Looking Statements
Catasys Forward-Looking Statements Except for statements of historical fact, the matters presented in this presentation are forward-looking and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements reflect numerous assum
Slide 3: Business Overview
Catasys Business Overview Catasys, Inc. (CATS) provides specialized healthcare management services to health plans and employers through its OnTrak™ Program. Catasys' OnTrak™ Program: Designed to improve member health Results in lower costs to the insurer where behavioral health conditions are exace
Slide 4: Cost Pressure
Catasys Cost Pressure @ Health Plans are under pressure to reduce costs @ Premiums up 100% in last 10 years @ Healthcare spending growth is expected to accelerate in 2015 ® PricewaterhouseCoopers’s Health Research Institute forecasts medical cost growth of 6.8% over all in 2015 vs. 6.5% in 2014 rice
Slide 5: $21 Billion Problem = $2 Billion Market Opportunity
Catasys $21 Billion Problem = $2 Billion Market Opportunity Catasys seeks to improve the lives of patients through its unique integrated evidence based medical and psychosocial 52-week outpatient program High cost health plan members with substance use disorders: (alcoholics, cocaine, methamphetamin
Slide 6: Challenges for Health Plans Dealing with High Cost Members with Substance Use Disorders
Catasys Challenges for Health Plans Dealing with High Cost Members with Substance Use Disorders . Annual Claims: $27,500 vs. $3,250 @ High Cost of Treatments: Substance dependent (SD) members cost commercial health plans 8 times more than other members: average of $27,500 annually versus $3,250 $27,
Slide 7: The Catasys OnTrak Solution
Catasys The Catasys OnTrak™ Solution § Initial focus on the high cost substance abuse populations for health plans ® Proven results: 50% reduction in health care cost for members enrolled in OnTrak™ program. @ Decreases medical hospital days (ambulance usage, E.R. visits, etc.) through identificatio
Slide 8: Key Features of OnTrak
Key Features of OnTrak™ Ongoing Outreach and Engagement Evidence Based Treatment Protocols Integrated Medical and Psychosocial Treatment Development of Select Provider Networks Provider Training and Ongoing Evaluations Member Electronic Health Record Care Coach Support Predictive Modeling and Analyt
Slide 9: Catasys Business Model
Catasys Catasys Business Model @ Contracts with Health Plans @ Enroll members directly and with the Health Plans @ Monthly fees for Enrolled Members l® In some cases Catasys may charge an upfront case rate and share in a savings from program @ Network of medical and psychosocial providers are paid f
Slide 10: Current Catasys Clients
Catasys Current Catasys Clients ~1,800,000' Members Humana. aetna CENTENE @ COVENTRY orporation ] Health Care AY Reliant a @ Advantra’ & Medical Group sin from Coventry Health Care fallon 3 community Ith plan Atrius Health ue to member ulizaion
Slide 11: OnTrak program is in Kansas, Louisiana, Florida, Massachusetts and other states
OnTrak™ program is in Kansas, Louisiana, Florida, Massachusetts, Oklahoma, West Virginia, Kentucky, Wisconsin and New Jersey Recent customer expansion into Florida (Humana) Recently announced national health plan starting in New Jersey (Aetna) 10
Slide 12: Growth Strategy
Catasys Growth Strategy Year-Over-Year Growth ® 78% increase in enrollment in first 9 months of 2014 compared with the same period in 2013 ® 105% increase in enrollment in 2013 compared with 2012 Increasing Enrollments into Additional States ® Existing customers have expanded from initial launch Cov
Slide 13: Growth Potential - Moving Toward Profitability
Catasys Growth Potential - Moving Toward Profitability Commercial Equivalent Members Covered! ~1,800,000 Approx. Breakeven Coverage? 1,500,000 Sales Pipeline? 9,900,00 Contract Discussion/Data Analysis* 4,000,000 Potential Market Commercial Equivalent 196,000,000 12
Slide 14: Catasys Revenue Model
Catasys Catasys Revenue Model (1M Covered Lives) Commercial Medicare | Incidence of SD (1.9% / 2.6%) 19,000 26,000 | Eligible (.450% / 1.12%) 4,500 11,200 | Assumed 20% enrollment in program 900 2,240 | Revenue per enrolled member at 80% retention Revenue per million coveredmembers $6,120,000 $16,66
Slide 15: No Direct Competition
Catasys No Direct Competition Currently SD treatment is sub-optimally managed by behavioral health organizations under fixed fee contracts ® Most high cost SD users are never identified (passive) @ Focus on behavioral health utilization, not total patient cost @ Under-diagnosis and under-treatment r
Slide 16: Current system does not identify or address high cost substance dependence members
Current system does not identify or address high cost substance dependence members: ® 74% of SD members have no behavioral claims. ®@ Untreated SD members generate high hospital costs from medical events. ® Catasys has unique, proprietary data analytics and screening. m Proprietary outreach program
Slide 17: OnTrak Integrated Treatment Approach
OnTrak™ Integrated Treatment Approach Merges engagement. Leverages evidence - Establishes treatment Coordinates care delivery medical, psychosocial and based med. interventions protocols, standards and & reduces practice pattern 52 weeks of care coaching and best practices outcome metrics variation
Slide 18: Terren S. Peizer, Chairman, Founder & CEO
Terren S.Peizer, Chairman, Founder & CEO + Founderofseveral health care andlife science companies + Extensive background in venture capita, investing, mergers and acquisitions, corporate finance + Held senior executive positions with investment banking firms Goldman Sachs, First Boston and Drexel Bu
Slide 19: Market Snapshot
Catasys Market Snapshot Exchange and Ticker: OTCQB: CATS Stock Price (3/04/15): $2.20 Market Capitalization: $101.7M Fully Diluted Shares Outstanding: 48.43M Estimated Public Float: 19.81M 52-Week LowlHigh: $0.77-$2.45 Fiscal Year End: December 31 18
Slide 20: Investment Highlights
Catasys Investment Highlights Superior management team — with 50+ combined years of healthcare experience Proprietary technology and analytics that help identify the right members to engage Demonstrating >50% reduction in total healthcare costs Proven model has quarter-over-quarter growth as well as
Slide 21: The OnTrak program: Better health. Lower costs.
The OnTrak” program: Better health. Lower costs. a LS CONTACTS Corporate Office: Investor Relations: 11601 Wilshire Blvd., Suite 950 IRTH Communications Los Angeles, CA 90025 Andrew Haag Phone: 310-444-4300 Tel: 866-976-4784 Website: http://www.catasys.com Email: [email protected]